Abstract
Background Gut function is vital for human health, and defecation frequency can serve as a fundamental marker including various abnormal patterns. However, the link between a defecation pattern and future adverse events in patients with acute coronary syndrome (ACS) remains uncertain. The aim of this study was to investigate the association between defecation patterns during hospitalization and future cardiovascular events in patients with ACS.
Methods This two-center retrospective observational cohort study included 1949 patients hospitalized for ACS between 2012 and 2019. For a comprehensive assessment of defecation in a general ward, we examined three indicators: “frequency of non-defecation days,” “consecutive non-defecation days,” and “maximum daily defecation frequency,” in addition to “average daily defecation frequency”. Patients were divided according to Youden index-derived cutoff values of each defecation frequency indicators. The primary outcome was a composite of all-cause mortality, myocardial infarction, ischemic stroke, and hemorrhagic stroke.
Results During the follow-up period (median, 48 months; IQR 30–74 months), 405 of 1949 (20.8%) patients developed the primary outcome. In total, 229 patients died (96 cardiovascular deaths and 133 non-cardiovascular deaths), and there were 142, 57, 28, and 113 patients with non-fatal myocardial infarction, nonfatal ischemic stroke, nonfatal hemorrhagic stroke, and hospitalized due to heart failure, respectively. High “frequency of non-defecation days” (≥33.5%) (hazard ratio [HR], 1.507; 95% confidence interval [95%CI], 1.191–1.907; P=0.0006) and high “maximum daily defecations frequency” (≥ 5 times in a single day) (HR, 1.670; 95%CI, 1.203–2.317; P=0.002) were associated with an increased risk of future cardiovascular events in the multivariate models. High “frequency of non-defecation days” and high “maximum daily defecations frequency” exhibit distinct characteristics: the former was associated with long-term cardiovascular mortality, all-cause mortality, myocardial infarction, and cerebral hemorrhage, while the latter was linked to cancer-related mortality, non-cardiovascular mortality, cerebral infarction, and heart failure.
Conclusions Among patients with ACS who survived to discharge, abnormal defecation patterns as assessed by increased frequency of non-defecation days and high-frequency defecations within a single day, were independently associated with future cardiovascular events.
What Is New?
This is the first study to investigate defecation patterns during the acute phase in patients with ACS and utilize reliable records of defecation during hospitalization rather than relying on survey-based assessments.
In patients with ACS, both increased frequency of non-defecation days and high-frequency defecations within a single day were independently associated with an increased risk of future cardiovascular events, controlling for various confounding factors including age, severity of ACS, medications, and dietary intake.
What Are the Clinical Implications?
Abnormal defecation patterns, such as frequent non-defecation days and high-frequency defecations within a single day, serve as indicators of “gut frailty.”
The presence of these abnormal defecation patterns may suggest a residual risk in patients post-ACS. Additional research is essential to explore the underlying mechanisms and potential therapeutic interventions.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This is a retrospective observational study.
Funding Statement
This research was supported by a grant from the Japan Society for the Promotion of Science (JSPS) under Grant-in-Aid for Scientific Research (Kakenhi) [grant number 18K15896 and 21K08083].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted in accordance with the guidelines of the Institutional Ethics Committees of Yokohama City University Hospital and Kumamoto University Hospital, which provided the ethical approvals (approval number 2766).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data is available upon approval. It will be necessary to provide a detailed protocol for the proposed study, to provide the approval of an ethics committee, to supply information about the funding and resources one has to carry out the study, and to consider inviting the original authors to participate in the re-analysis.
